Literature DB >> 26888781

Toll-like receptor 5 and 7 expression in adenoid cystic carcinoma of major salivary glands.

K Hirvonen1,2, L Bäck3, C Haglund4, I Leivo5, L Jouhi3, A A Mäkitie3, J Hagström6.   

Abstract

Adenoid cystic carcinoma (ACC) of the salivary glands has a poor long-term prognosis and high metastatic rate. Toll-like receptors (TLRs) have been related to tumour progression but have also tumour growth-inhibiting responses. To the best of our knowledge, they have not been studied previously in ACC. We studied the immunoexpression of TLR 5 and 7 in ACC of the major salivary glands. From a cohort of 54 patients with ACC of the major salivary glands treated at the Department of Otorhinolaryngology-Head and Neck Surgery, Helsinki University Hospital, Helsinki, Finland in 1974-2009, there were 34 primary tumours and six metastases available for immunohistochemical analysis. Immunohistochemical expression of TLR 5 and 7 were correlated to clinicopathological findings and patient survival. Both TLR 5 and 7 were expressed in ACCs and their metastases, mostly on the cell membranes. The expression was heterogeneous in individual tumours. TLR 5 was expressed less in male samples, and TLR 7 had lower expression in ACCs with solid growth pattern. No correlation with survival was found. In the normal salivary gland, the TLR 5 and 7 expression was mainly negative. Both TLR 5 and 7 are expressed in salivary adenoid cystic carcinoma on the cell membranes as well as in cytoplasm.

Entities:  

Keywords:  Head and neck cancer; Immunohistochemistry; Metastasis; Salivary gland cancer

Mesh:

Substances:

Year:  2016        PMID: 26888781     DOI: 10.1007/s13277-016-4971-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  21 in total

1.  Pattern of recurrent disease in major salivary gland adenocystic carcinoma.

Authors:  Karoliina Hirvonen; Leif Bäck; Kauko Saarilahti; Ilmo Leivo; Jaana Hagström; Antti A Mäkitie
Journal:  Virchows Arch       Date:  2015-04-03       Impact factor: 4.064

2.  Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome.

Authors:  M P Spachidou; E Bourazopoulou; C I Maratheftis; E K Kapsogeorgou; H M Moutsopoulos; A G Tzioufas; M N Manoussakis
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

Review 3.  Pathogen recognition and innate immunity.

Authors:  Shizuo Akira; Satoshi Uematsu; Osamu Takeuchi
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

4.  Chronic ulcerative colitis associated with malignant disease. 1928.

Authors:  J A Bargen
Journal:  Dis Colon Rectum       Date:  1994-07       Impact factor: 4.585

5.  Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.

Authors:  Lauri Jouhi; Neeta Datta; Suvi Renkonen; Timo Atula; Antti Mäkitie; Caj Haglund; Abdirisak Ahmed; Stina Syrjänen; Reidar Grénman; Eeva Auvinen; Sanna Lehtonen; Jaana Hagström
Journal:  Tumour Biol       Date:  2015-05-05

Review 6.  Dual character of Toll-like receptor signaling: pro-tumorigenic effects and anti-tumor functions.

Authors:  Li Yu; Liantang Wang; Shangwu Chen
Journal:  Biochim Biophys Acta       Date:  2012-12-08

7.  Toll-like receptors -4 and -5 in oral and cutaneous squamous cell carcinomas.

Authors:  Abdirisak Ahmed Haji Omar; Johanna Korvala; Caj Haglund; Susanna Virolainen; Valtteri Häyry; Timo Atula; Risto Kontio; Jarmo Rihtniemi; Antti Pihakari; Timo Sorsa; Jaana Hagström; Tuula Salo
Journal:  J Oral Pathol Med       Date:  2014-07-22       Impact factor: 4.253

8.  Toll-like receptor in salivary glands from patients with Sjögren's syndrome: functional analysis by human salivary gland cell line.

Authors:  Atsushi Kawakami; Koto Nakashima; Mami Tamai; Hideki Nakamura; Nozomi Iwanaga; Keita Fujikawa; Toshiyuki Aramaki; Kazuhiko Arima; Naoki Iwamoto; Kunihiro Ichinose; Makoto Kamachi; Hiroaki Ida; Tomoki Origuchi; Katsumi Eguchi
Journal:  J Rheumatol       Date:  2007-04-01       Impact factor: 4.666

9.  Toll-like receptor 9 expression in mucoepidermoid salivary gland carcinoma may associate with good prognosis.

Authors:  Johanna Korvala; Teresa Harjula; Kristiina Siirilä; Alhadi Almangush; Katri Aro; Antti A Mäkitie; Reidar Grénman; Tuomo J Karttunen; Ilmo Leivo; Joonas H Kauppila; Tuula Salo
Journal:  J Oral Pathol Med       Date:  2014-02-03       Impact factor: 4.253

10.  TLR7 promotes tumor progression, chemotherapy resistance, and poor clinical outcomes in non-small cell lung cancer.

Authors:  Saradiya Chatterjee; Lucile Crozet; Diane Damotte; Kristina Iribarren; Catherine Schramm; Marco Alifano; Audrey Lupo; Julien Cherfils-Vicini; Jeremy Goc; Sandrine Katsahian; Mohammad Younes; Marie Caroline Dieu-Nosjean; Wolf Herman Fridman; Catherine Sautès-Fridman; Isabelle Cremer
Journal:  Cancer Res       Date:  2014-07-29       Impact factor: 12.701

View more
  2 in total

1.  The Expression of Toll-like Receptors in Normal Human and Murine Gastrointestinal Organs and the Effect of Microbiome and Cancer.

Authors:  Heikki Huhta; Olli Helminen; Joonas H Kauppila; Tuula Salo; Katja Porvari; Juha Saarnio; Petri P Lehenkari; Tuomo J Karttunen
Journal:  J Histochem Cytochem       Date:  2016-07-01       Impact factor: 2.479

2.  Prognostic role of Toll-like receptors in cancer: a meta-analysis.

Authors:  Qingwen Wang; Xiankai Zhang; Tingting Xiao; Chenhua Pan; Xing Liu; Yulan Zhao
Journal:  Ther Clin Risk Manag       Date:  2018-07-30       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.